I am a breastfeeding mother and i want to know if it is safe to use Ivosidenib [INN]? Is Ivosidenib [INN] safe for nursing mother and child? Does Ivosidenib [INN] extracts into breast milk? Does Ivosidenib [INN] has any long term or short term side effects on infants? Can Ivosidenib [INN] influence milk supply or can Ivosidenib [INN] decrease milk supply in lactating mothers?
No information is available on the clinical use of Ivosidenib [INN] during breastfeeding. Because Ivosidenib [INN] is 92 to 96% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is about 93 hours and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during erlotinib therapy and for 1 month after the dose.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.